University of Cape Town
Also known as: Centre for TB Research and Innovation, UCT Lung Institute | Centre for Tuberculosis Research Innovation, University of Cape Town Lung Institute | CIDRI-Africa, University of Cape Town | Department of Medicine, University of Cape Town | East London Hospital Complex, South Africa | Effective Care Research Unit, East London Hospital Complex, South Africa | Effective Care Research Unit, Frere Maternity Hospital, East London Hospital Complex | Hatter Institute for Cardiovascular Disease in Africa | Hatter Institute for Cardiovascular Research In Africa (HICRA), University of Cape Town | Mark Hatherill | Nkanyiso Hadebe | Professor & Co-Director, University of Cape Town | Professor Karen I Barnes | Red Cross Children's Hospital, University of Cape Town | The Abdul Latif Jameel Poverty Action Lab | UCT | UCT Diabetes Clinical Trials Unit - Faculty of Health Sciences - South-Africa | UCT Lung Institute | UCT Lung Institute, Cape Town, South Africa | UCT Lung Institute, University of Cape Town | University Cape Town | University of Cape | University of Cape Town | University of Cape Town, Cape Town, South Africa | University of Cape Town, Faculty of Health Sciences | University of Cape Town, Groote Schuur Hospital | University of Cape Town Lung Institute | University of Cape Town Lung Institute (Pty) Ltd | University of Cape Town Lung Institute Pty (Ltd) | University of Cape Town Lung Institute (Pty) Ltd, South Africa | University of Cape Town South African Tuberculosis Vaccine Initiative | Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town | Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1993Last known activity
Nov 30, 2024
Timeline
1820s
- Jan 1, 1829
University of Cape Town— Founded
Drugs by trial phase (117 distinct, 110 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (49 own, 0 via acquisition)
Phase 2 (22 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Chemical and Drug Induced Liver Injury
- Conjunctivitis
- Conjunctivitis, Allergic
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Epilepsy
- Extensively Drug-Resistant Tuberculosis
- Fetal Alcohol Spectrum Disorders
- Gonorrhea
- Heart Diseases
- Heart Failure
- Hepatitis
- HIV Infections
- Hypersensitivity
- Hypertension
- Immune Reconstitution Inflammatory Syndrome
- Immunologic Deficiency Syndromes
- Inflammation
- Latent Tuberculosis
- Lung Diseases
- Lymphoma
- Malaria
- Malaria, Falciparum
- Malnutrition
- Meningitis
- Meningitis, Cryptococcal
- Multiple Chronic Conditions
- Mycoses
- Mycosis Fungoides
- Pericarditis
- Pericarditis, Tuberculous
- Reperfusion Injury
- Rheumatic Diseases
- Rheumatic Heart Disease
- Severe Acute Malnutrition
- Severe Acute Respiratory Syndrome
- Sprains and Strains
- Status Epilepticus
- Syndrome
- Syphilis
- Trichomonas Vaginitis
- Tuberculosis
- Tuberculosis, Meningeal
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Pulmonary
- Vaginitis
- Ventricular Dysfunction
- Ventricular Dysfunction, Left
Recent trials (50)
- NCT06590428CollaboratorN/ANov 30, 2024
- NCT06590428OfficialN/ANov 30, 2024
- NCT06281834CollaboratorPhase 1Sep 30, 2024
- NCT06025916CollaboratorPhase 4Sep 27, 2023
- NCT05923333Lead sponsorN/AJul 31, 2023
- NCT05923333Reponsible party - principal investigatorN/AJul 31, 2023
- NCT05556746Overall official - principal investigatorPhase 2Mar 31, 2023
- NCT05556746CollaboratorPhase 2Mar 31, 2023
- NCT05556746OfficialPhase 2Mar 31, 2023
- NCT05580666Overall official - principal investigatorPhase 3Feb 28, 2023
- NCT05681871Lead sponsorPhase 2/Phase 3Jan 16, 2023
- NCT05681871Reponsible party - principal investigatorPhase 2/Phase 3Jan 16, 2023
- NCT05681871Sponsor investigatorPhase 2/Phase 3Jan 16, 2023
- NCT04975178CollaboratorPhase 3Jul 31, 2022
- NCT04975178Overall official - principal investigatorPhase 3Jul 31, 2022
Details
- Founded
- Cape Town, ZA Jan 1, 1829
- Last known activity
- Nov 30, 2024